Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
111.90
-4.23 (-3.64%)
Nov 4, 2024, 4:00 PM EST - Market closed
Cardinal Health Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
Revenue | 224,454 | 226,827 | 204,979 | 181,326 | 162,467 | 152,922 | Upgrade
|
Revenue Growth (YoY) | 6.87% | 10.66% | 13.04% | 11.61% | 6.24% | 5.08% | Upgrade
|
Cost of Revenue | 216,881 | 219,413 | 198,105 | 174,842 | 155,689 | 146,054 | Upgrade
|
Gross Profit | 7,573 | 7,414 | 6,874 | 6,484 | 6,778 | 6,868 | Upgrade
|
Selling, General & Admin | 5,091 | 5,000 | 4,800 | 4,512 | 4,533 | 4,572 | Upgrade
|
Operating Expenses | 5,369 | 5,268 | 5,085 | 4,836 | 4,984 | 5,096 | Upgrade
|
Operating Income | 2,204 | 2,146 | 1,789 | 1,648 | 1,794 | 1,772 | Upgrade
|
Interest Expense | -98 | -77 | -78 | -147 | -180 | -238 | Upgrade
|
Currency Exchange Gain (Loss) | 29 | 27 | -13 | - | -8 | -11 | Upgrade
|
Other Non Operating Income (Expenses) | 12 | 8 | 2 | -22 | 55 | 12 | Upgrade
|
EBT Excluding Unusual Items | 2,147 | 2,104 | 1,700 | 1,479 | 1,661 | 1,535 | Upgrade
|
Merger & Restructuring Charges | -190 | -191 | -95 | -101 | -114 | -122 | Upgrade
|
Impairment of Goodwill | -90 | -675 | -1,200 | -2,100 | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | 2 | -2 | 579 | Upgrade
|
Gain (Loss) on Sale of Assets | -53 | - | - | - | -60 | - | Upgrade
|
Asset Writedown | 51 | 41 | -46 | 40 | -19 | -7 | Upgrade
|
Legal Settlements | -79 | -78 | 304 | -94 | -1,129 | -5,741 | Upgrade
|
Other Unusual Items | - | - | - | -10 | -14 | -16 | Upgrade
|
Pretax Income | 1,786 | 1,201 | 663 | -784 | 323 | -3,772 | Upgrade
|
Income Tax Expense | 505 | 348 | 332 | 153 | -289 | -79 | Upgrade
|
Earnings From Continuing Operations | 1,281 | 853 | 331 | -937 | 612 | -3,693 | Upgrade
|
Net Income to Company | 1,281 | 853 | 331 | -937 | 612 | -3,693 | Upgrade
|
Minority Interest in Earnings | -1 | -1 | -1 | -1 | -1 | -3 | Upgrade
|
Net Income | 1,280 | 852 | 330 | -938 | 611 | -3,696 | Upgrade
|
Net Income to Common | 1,280 | 852 | 330 | -938 | 611 | -3,696 | Upgrade
|
Net Income Growth | 515.38% | 158.18% | - | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 244 | 245 | 261 | 279 | 292 | 293 | Upgrade
|
Shares Outstanding (Diluted) | 246 | 247 | 262 | 279 | 294 | 293 | Upgrade
|
Shares Change (YoY) | -3.91% | -5.73% | -6.09% | -5.10% | 0.34% | -2.66% | Upgrade
|
EPS (Basic) | 5.26 | 3.48 | 1.26 | -3.36 | 2.09 | -12.61 | Upgrade
|
EPS (Diluted) | 5.21 | 3.45 | 1.26 | -3.37 | 2.08 | -12.61 | Upgrade
|
EPS Growth | 539.70% | 173.81% | - | - | - | - | Upgrade
|
Free Cash Flow | 1,078 | 3,251 | 2,363 | 2,788 | 2,029 | 1,585 | Upgrade
|
Free Cash Flow Per Share | 4.38 | 13.16 | 9.02 | 9.99 | 6.90 | 5.41 | Upgrade
|
Dividend Per Share | 2.012 | 2.007 | 1.988 | 1.968 | 1.940 | 1.920 | Upgrade
|
Dividend Growth | 0.99% | 0.99% | 1.00% | 1.45% | 1.04% | 0.52% | Upgrade
|
Gross Margin | 3.37% | 3.27% | 3.35% | 3.58% | 4.17% | 4.49% | Upgrade
|
Operating Margin | 0.98% | 0.95% | 0.87% | 0.91% | 1.10% | 1.16% | Upgrade
|
Profit Margin | 0.57% | 0.38% | 0.16% | -0.52% | 0.38% | -2.42% | Upgrade
|
Free Cash Flow Margin | 0.48% | 1.43% | 1.15% | 1.54% | 1.25% | 1.04% | Upgrade
|
EBITDA | 2,924 | 2,856 | 2,481 | 2,340 | 2,577 | 2,685 | Upgrade
|
EBITDA Margin | 1.30% | 1.26% | 1.21% | 1.29% | 1.59% | 1.76% | Upgrade
|
D&A For EBITDA | 720 | 710 | 692 | 692 | 783 | 913 | Upgrade
|
EBIT | 2,204 | 2,146 | 1,789 | 1,648 | 1,794 | 1,772 | Upgrade
|
EBIT Margin | 0.98% | 0.95% | 0.87% | 0.91% | 1.10% | 1.16% | Upgrade
|
Effective Tax Rate | 28.28% | 28.98% | 50.08% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.